Tolerance induced by chronic inhaled antigen in a murine asthma model is not mediated by endotoxin  by Schramm, C.M. et al.
Biochimica et Biophysica Acta 1762 (2006) 499–501
http://www.elsevier.com/locate/bbaRapid report
Tolerance induced by chronic inhaled antigen in a murine asthma model is
not mediated by endotoxin
C.M. Schramm a,⁎, L. Guernsey b, E. Secor b, R.S. Thrall b
a Department of Pediatrics, University of Connecticut Health Center, 263 Farmington Avenue, Farmington, CT 06030, USA
b Department of Medicine, Pulmonary Research Consortium, University of Connecticut Health Center, 263 Farmington Avenue, Farmington, CT 06030, USA
Received 19 January 2006; received in revised form 11 February 2006; accepted 13 February 2006
Available online 9 March 2006Abstract
Ovalbumin (OVA)-sensitized wildtype (WT) and endotoxin-resistant (ER) mice developed similar degrees of airways eosinophilia and serum
OVA-specific IgE levels after acute aerosolized OVA challenge. WT mice demonstrated methacholine hyperreactivity, whereas ER mice showed
no change in responsiveness. With chronic aerosolized OVA challenge, both WT and ER mice developed local tolerance, with resolution of airway
eosinophilia but persistence of anti-OVA IgE in serum. Thus, the development of local tolerance with chronic aerosol exposure to OVA is
independent of any potential effects of endotoxin in the OVA aerosol solution.
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Epidemiological studies have implicated endotoxin as a
protective factor against the development of asthma [1,2].
Conversely, exposure to endotoxin can lead to exacerbations of
existing asthma [3,4]. Similarly, studies in animal asthma
models using ovalbumin (OVA) as the inciting allergen have
reported both inhibitory and pro-inflammatory effects of
endotoxin [5–9]. At least some of the variability of these
responses can be attributed to differences in timing and dosing
of the endotoxin. Moreover, commercial OVA preparations are
highly contaminated with endotoxin. The high-grade chicken
egg white albumin (Sigma Grade V OVA, over 98% pure) used
in our experiments contains up to 0.4 μg endotoxin per 1 mg
OVA (i.e., 0.04% contamination) [10]. Other commercial OVA
preparations may contain as high as 10 μg of endotoxin per 1
mg OVA (1% contamination) [5].
Investigations of endotoxin as a modulatory factor in animal
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OVA develop a biphasic response to inhaled OVA challenge
[10]. Acute (3–10 days) aerosol exposure results in Th2
cytokine production, OVA-specific IgE generation, airway
eosinophilia, and hyperresponsiveness to methacholine — all
characteristics of allergic airway disease (AAD). In contrast,
chronic (6–11 week) aerosol exposure results in local
inhalational tolerance (LIT), wherein airway inflammatory
responses are attenuated but systemic IgE production persists.
We attributed the development of LIT to an antigen-dependent
mechanism; however, the demonstration that our aerosolized
OVA solution contained 0.6–4.1 μg/ml of LPS [10] raised the
consideration that LIT was due to chronic inhalation of the
contaminating endotoxin. The present study was designed to
assess the progression from AAD to LIT in endotoxin-resistant
mice, in order to determine if chronic inhalation of endotoxin
was required for the development of LIT.
To address this question, we obtained adult wildtype C57BL/
6J (WT) and endotoxin-resistant C57BL/10ScN (ER) mice
from The Jackson Laboratory (Bar Harbor, ME). These ER
mice are a TLR4 deletion-based knockout strain. Their use in
this study assumed that the relevant actions of inhaled LPS in
murine OVA asthma models are mediated through the Toll4
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sensitized to OVA by receiving 3 weekly intraperitoneal
injections of 25 μg OVA (grade V; Sigma Chemical Co., St.
Louis, MO) and 2 mg aluminum hydroxide (alum) suspended in
0.5 ml of saline [10]. One week after the last injection, the mice
were exposed to 1% aerosolized OVA either for 1 h/day for 7
days (acute exposure; AAD group), or for 1 h/day for 7 days
followed by 5 days/week for 4 weeks (chronic exposure; LIT
group). The OVA aerosols were generated by a BANG
nebulizer (CH Technologies, Westwood, NJ) into a 7.6-L, 48-
port inhalation exposure chamber to which mice placed in
plastic restraint tubes were attached (CH Technologies).
Chamber airflow was 6 L/min, and aerosol particle size of
OVA was monitored by gravimetric analysis with a Mercer
cascade impactor (In-Tox Products, Moriarty, NM). The mass
median aerodynamic diameter (MMAD) and geometric stan-
dard deviation were 1.4 and 1.6 μm, respectively. Airway
responses to methacholine were assessed by whole-body
barometric plethysmography performed 12 h after the third
OVA aerosol in acute animals or during the final week of
exposure in chronic animals [10]. Bronchoalveolar lavage
(BAL) cell counts and serum OVA-specific IgE levels were
determined at the time of sacrifice [10].
Relative to naive animals, OVA-sensitized mice exposed to 7
days of inhaled OVA challenges demonstrated marked airway
inflammation, characterized by increased total BAL cells and
increased numbers of eosinophils and lymphocytes (Fig. 1A).
There was no difference in the degree or composition of the
BAL cellular inflammatory response between the WT and ER
mice. In contrast to naive mice that had no detectable OVA-
specific IgE, WT and ER mice developed similar levels of anti-
OVA IgE following the sensitization and inhaled challenges
(15.4±0.5 μg/ml WT and 18.1±0.5 μg/ml ER; Fig. 1B).
Baseline sensitivity to inhaled methacholine, obtained in the
mice prior to inhaled OVA challenge), was also similar in WT
and ER mice (p2 methacholine concentration 25.5±3.1 mg/ml
WT and 24.0±2.6 mg/ml ER). The similar airway eosinophilia
and serum IgE responses in WT and ER mice suggested that theFig. 1. Panel A: BAL leukocyte counts in naive, AAD, and LITwildtype (WT) and en
bars), eosinophils (shaded bars), and lymphocytes (striped bars); * designates P<0.0
mice. Panel B: Serum OVA-IgE levels in naive, AAD, and LIT WT and ER mice.
between ER mice in the AAD and LIT phases. Panel C: Responsiveness to inhaled m
values; * designates P<0.05 vs. corresponding naive response, and † designates P<endotoxin contaminating our commercial OVA solutions was
not enough to modulate the development of AAD in our mice.
We have previously determined that our mice may have inhaled
5–35 ng/day of endotoxin [10]. This dose is substantially lower
than the microgram doses used by others to show inhibitory
effects of endotoxin on the development of allergic airway
responses [7,12].
Even though the airway eosinophilia and serum IgE
responses were similar in the two groups of mice, only the
WT mice developed increased sensitivity to methacholine.
After 3 inhaled OVA aerosol challenges, the WT mice
demonstrated a 2.6-fold increase in methacholine sensitivity
(Fig. 1C), while the ER mice showed no change in
responsiveness (P=0.040 vs. WT response). The failure of
ER resistant animals to demonstrate airway hyperresponsive-
ness during AAD was also shown in endotoxin-resistant BALB/
c mice lacking LPS binding protein [13]. Of interest, TLR2 and
TLR4 receptors have recently been identified in mouse [14] and
human airway smooth muscle [15]. Conceivably, stimulation of
these receptors with a low level of inhaled endotoxin may be
needed for the development of airways hyperreactivity during
inhaled antigen challenge.
With 6-week exposure to OVA aerosols, airway inflamma-
tory responses largely resolved (Fig. 1A). There was no
difference in the degree or composition of the BAL cellular
inflammatory response between the WT and ER mice. Airway
eosinophilia was completely ablated in both groups of mice.
Airway lymphocytosis was also greatly attenuated, although it
remained mildly increased compared to naive mice. Serum
levels of OVA-specific IgE remained elevated in chronic WT
and ER mice (Fig. 1B). There were no differences between
chronic WTand ER anti-OVA IgE levels; however, the levels of
anti-OVA IgE in LIT mice were lower than those in AAD mice
(P=0.024). Methacholine responsiveness was not repeated
because the ER mice did not demonstrate heightened reactivity
during AAD, and the increased responsiveness seen in WTmice
during AAD returns to baseline with progression to LIT [10,11].
Thus, the progression of our model from AAD to LIT was alsodotoxin-resistant (ER) mice. Data represent mean values for macrophages (open
5 for total cells, eosinophils, and lymphocytes in AAD vs. corresponding naive
Data represent mean±S.E.M. values; * designates P<0.05 for OVA-IgE levels
ethacholine in naive and AAD WT and ER mice. Data represent mean±S.E.M.
0.05 between WT and ER responses in similar conditions.
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since chronic exposure of sensitized mice to aerosolized OVA
resulted in the development of LIT in both WT and ER mice.
Exposure of naive BALB/c mice to 40 ng/ml inhaled LPS
before and during exposure to aerosolized OVA prevents the
development of IgE tolerance to systemic OVA administration
[9]; however, our model differs fundamentally from airway
antigen-induced systemic tolerance in that LIT develops after
AAD has been established and is localized to the lungs, with
lesser effects on systemic responses.
In summary, the development of LIT with chronic aerosol
exposure to OVA was independent of any potential effects of
endotoxin in the OVA aerosol solution, or of endotoxin arising
from cage litter and feces. In contrast, the development of
hyperresponsiveness to methacholine during AAD appeared to
be dependent on an intact endotoxin-signaling pathway,
suggesting that endotoxin may contribute to the acute airway
response in asthma.
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